Innovation funding for two researchers from the Department of Microbiology

Arranz (left) and Brunvoll
Arranz (left) and Brunvoll

The UiO Growth House help researchers to mature early-stage ideas. The University of Oslo has in 2026 allocated NOK 5 million for early-stage innovation projects in two categories

  • the idea and concept phase – project funding up to NOK 50 000. 
  • the test and further development phase – project funding up to NOK 400 000.

Two researchers from MIK were granted funding for their projects!

Lorena Arranz, Leader of the Stem Cells, Ageing and Cancer group and Deputy Director of SFF CRESCO, has received NOK 400 000 for the test and further development phase of a succinate analogue suitable for therapeutic applications in cancer.

“This support represents an important step forward in our quest to apply our research to improve the life of patients”, Arranz comments.

Sonja Hjellegjerde Brunvoll, Researcher in the Genome and Epigenome Regulation in Embryo Development, Ageing and Disease group, has received NOK 50 000 for her project ONCOFAST; Intermittent fasting during chemotherapy – a randomized feasibility study.

MIK Research congratulates both!

Links:

Lorena Arranz’s research group: OUH - Stem Cells, Ageing and Cancer

Personal profile, Sonia Hjellegjerde Brunvoll: OUH - Group members

Article about the funding, UiO: Knowledge in use: NOK 4,9 million to innovative UiO researchers - University of Oslo

 
Scroll to top